Fact CheckerSign in

NCT06674070Completed

SCN2A Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Population(Pakistan)

SCN2A, rs2304016 Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Epilepsy Patients (Pakistan)

Source: ClinicalTrials.gov · Last updated 5 Nov 2024

Brief summary (registry, in English)

The goal of this Observational study was to identify the effect of SCN2A gene polymorphism in the Paediatric epileptic Pakistani population. The main question it aims to answer is: to evaluate the effect of this genetic polymorphism on the clinical efficacy of Valproic acid Participants were prescribed Valproic acid after diagnosis of epilepsy.

Status (registry)
Completed
Study type
Observational
Enrollment
200 (actual)
First submitted
3 Sept 2024
Start date
1 Dec 2023
Primary completion date
31 Jul 2024
Lead sponsor
Riphah International University
Diseases
Epilepsy
NCT number
NCT06674070

What you commit to

  • Study type: Observational
  • Participants enrolled: 200
  • From 1 Dec 2023 to the primary completion date, 31 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients taking any other anti-epileptic drug.
  • Patients taking medications that interact with VPA.

Other illness

  • Patients with moderate or severe systemic diseases

Who the study is looking for

  • Epileptic Pakistani individuals of age between 1 to 12 years of either sex
  • Each patient had experienced two or more clinically confirmed, spontaneous epileptic seizures in the past.
  • Newly diagnosed patients started VPA 20 mg/kg (drug of the same brand was used for every patient throughout the study).

Age in the registry: 1 month to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IIMC, Riphah International University
Coordinator of this site? Confirm its status
IslamabadPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.